James West
-
Block estrogen to treat lung disease
Based on findings from Vanderbilt investigators and others, clinical trials of estrogen inhibition for pulmonary arterial hypertension have recently been approved and funded by the National Institutes of Health. Read MoreAug 17, 2017
-
Marrow cells’ role in pulmonary hypertension explored
Cells from the bone marrow participate in the development of pulmonary arterial hypertension (PAH), and they can also protect against it, according to new findings from a team of Vanderbilt University Medical Center investigators. Read MoreJul 28, 2016
-
Hypertension hiatus
New findings offer a potential strategy for preventing heritable pulmonary arterial hypertension. Read MoreFeb 23, 2016
-
Cattle Research Yields Lung Disease Clues
Vanderbilt researchers have discovered a genetic mutation that causes pulmonary hypertension, which leads to brisket disease, a life-threatening pulmonary condition that affects cattle grazed at high altitude. Read MoreJul 31, 2015
-
VU team’s cattle research may yield lung disease clues
Vanderbilt University researchers have found a genetic mutation that causes pulmonary hypertension in cattle grazed at high altitude, and which leads to a life-threatening condition called brisket disease. Read MoreApr 15, 2015